2,6-Dichloro-5-fluoropyridin-3-amine

We are 2,6-Dichloro-5-fluoropyridin-3-amine CAS:152840-65-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 2,6-Dichloro-5-fluoropyridin-3-amine
CAS.NO: 152840-65-8
Synonyms:2,6-dichloro-5-fluoropyridin-3-amine;
3-amino-2,6-dichloro-5-fluoropyridine;
Molecular Formula: C5H3Cl2FN2
Molecular Weight: 180.99500
 
Physical and Chemical Properties:
Density: 1.6±0.1 g/cm3
Melting point: /
Boiling point: 295.7±35.0 °C at 760 mmHg
Flash point: 132.7±25.9 °C
Index of Refraction: 1.594
 
Specification:
Appearance: Yellow solid
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:  used in the pharmaceutical intermediate

2,6-Dichloro-5-fluoropyridin-3-amine


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.2234-16-4 The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.diethyl 2-acetamido-2-(2-phenylethyl)propanedioate CAS:5463-92-3 We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.1609080-03-6 According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.

Related Products
Product Name
3-Amino-6-bromopyridine View Details
2-Amino-4-chloropyrimidine View Details
4-(4-Chlorophenyl)piperidin-4-ol View Details
2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile manufacturer 4-Cloromethyl-5-methyl-1,3-dioxol-2-one manufacturer Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride manufacturer [2-Oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonic Acid Dimethyl Ester manufacturer 3-[(1S)-1-(dimethylamino)ethyl]phenol manufacturer